Advertisement
Screener

Citius Pharmaceuticals, Inc. (CTXR) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

1.7 / 5 stars · 18/54 Roast Me

Citius Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures

Citius Pharmaceuticals, Inc. (CTXR) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures of 88.50 thousand shares for the 9-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.

Discontinued › Shareholders' Equity

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod · last filed 2023-08-14

  • 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month 88.50K shares.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures 9 month
2023-06-3088.50K shares
10-Q · filed 2023-08-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Korsana Biosciences, Inc. (CYCN)United States$0.016B
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Pasithea Therapeutics Corp. (KTTA)United States$0.017B-0.81
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Allarity Therapeutics, Inc. (ALLR)United States$0.017B-1.66
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
PALATIN TECHNOLOGIES INC (PTN)United States$0.017B-5.36